Provenge: implications for measuring effectiveness
http://www.hemonctoday.com/article.aspx?rid=68401
Quote:
<center>http://www.hemonctoday.com/images/ho...fastfactsa.gif</center> |
Re: Provenge: implications for measuring effectiveness
Rich,
Interesting information. Were you trying to demonstrate the lengthy process of getting a new drug approved? I found this long article about Provenge [posted in April, 2010]: http://www.cancer.org/AboutUs/DrLens...te-Cancer.aspx |
Re: Provenge: implications for measuring effectiveness
Mostly pointing out how the usual tumor shrinkage/RECIST criteria gauging of effectiveness didn't predict the survival benefit. I'm wondering whether some therapies, maybe immunotherapies in particular, are abandoned prematurely due to shortsighted criteria. It also might tie into the cancer stem cell theory/issue in that they are considered a less visible but maybe important minority of the cells.
|
All times are GMT -7. The time now is 06:15 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021